In the same HNC radiotherapy model, salivary gland flow in response to pilocarpine, a common pharmaceutical treatment for xerostomia, was improved by KGF gene transfer, and this benefit was in the absence of any effect on the growth or radiation sensitivity of squamous cell carcinoma tumours in the transduced animals [120]. This evidence concerns the gene FGF7 and neoplasm.